Florida Senate - 2014 SB 1030 By Senators Bradley, Bean, and Brandes 7-01036C-14 20141030__ 1 A bill to be entitled 2 An act relating to medical-grade marijuana and 3 cannabis; creating s. 456.60, F.S.; defining terms; 4 authorizing specified physicians to prescribe to 5 specified patients medical-grade marijuana; providing 6 conditions; providing duties of the Department of 7 Health; requiring the department to create a 8 compassionate use registry; providing requirements for 9 the registry; requiring the department to authorize a 10 specified number of dispensing organizations; 11 providing requirements and duties for a dispensing 12 organization; providing exceptions to specified laws; 13 amending s. 893.02, F.S.; revising the definition of 14 the term “cannabis” for purposes of the Florida 15 Comprehensive Drug Abuse Prevention and Control Act 16 and as applicable to certain criminal offenses 17 proscribing the sale, manufacture, delivery, 18 possession, or purchase of cannabis, to which 19 penalties apply; providing an effective date. 20 21 Be It Enacted by the Legislature of the State of Florida: 22 23 Section 1. Section 456.60, Florida Statutes, is created to 24 read: 25 456.60 Compassionate use of medical-grade marijuana.— 26 (1) DEFINITIONS.—As used in this section, the term: 27 (a) “Dispensing organization” means an organization 28 approved by the department to cultivate, process, and dispense 29 medical-grade marijuana pursuant to this section. 30 (b) “Medical-grade marijuana” means a substance that 31 contains no more than 0.5 percent or less of any 32 tetrahydrocannabinol and at least 15 percent cannabidiol and 33 that is dispensed only from a dispensing organization. 34 (c) “Medical use” means administration of the prescribed 35 amount of medical-grade marijuana. The term does not include the 36 possession, use, or administration by smoking. The term also 37 does not include the transfer of medical-grade marijuana to a 38 person other than the qualified patient to whom it was 39 prescribed or the qualified patient’s legal representative on 40 behalf of the qualified patient. 41 (d) “Qualified patient” means a resident of this state who 42 has been added to the compassionate use registry by a physician 43 licensed under chapter 458 or chapter 459 to receive medical 44 grade marijuana from a dispensing organization. 45 (e) “Smoking” means burning or igniting a substance and 46 inhaling the smoke. Smoking does not include the use of a 47 vaporizer. 48 (2) PHYSICIAN PRESCRIBING.—A physician licensed under 49 chapter 458 or chapter 459 who has examined and treated a 50 patient suffering from a physical medical condition, or from 51 treatment for a medical condition, which chronically produces 52 symptoms of seizures or severe and persistent muscle spasms may 53 prescribe for the patient’s medical use medical-grade marijuana 54 to treat or alleviate such symptoms if no other satisfactory 55 alternative treatment options exist for that patient and all of 56 the following conditions apply: 57 (a) The patient is a permanent resident of this state. 58 (b) The physician has treated the patient for his or her 59 symptoms or a medical condition in which his or her symptoms 60 were present for at least 6 months. 61 (c) The physician has tried alternate treatment options 62 that have not alleviated the patient’s symptoms. 63 (d) The physician determines the risks of prescribing 64 medical-grade marijuana are reasonable in light of the potential 65 benefit for that patient. If a patient is younger than 18 years 66 of age, a second physician must concur with this determination, 67 and such determination must be documented in the patient’s 68 medical record. 69 (e) The physician registers as the prescriber of medical 70 grade marijuana for the named patient on the compassionate use 71 registry maintained by the department and updates the registry 72 to reflect the prescription contents as prescribed. The 73 physician shall inactivate the patient’s registration when 74 treatment is discontinued. 75 (f) The physician maintains a patient treatment plan that 76 includes the dose, route of administration, planned duration, 77 and monitoring of the patient’s symptoms and other indicators of 78 tolerance or reaction to the medical-grade marijuana. 79 (g) The physician submits the patient treatment plan 80 quarterly to the University of Florida College of Pharmacy for 81 research on the safety and efficacy of medical-grade marijuana 82 on patients with such symptoms. 83 (3) DUTIES OF THE DEPARTMENT.—The department shall: 84 (a) Create a secure, electronic, and online compassionate 85 use registry for the registration of physicians and patients as 86 provided under this section. The registry must be accessible to 87 law enforcement agencies and to a dispensing organization in 88 order to verify patient authorization for medical-grade 89 marijuana and record the medical-grade marijuana dispensed. The 90 registry must prevent an active registration of a patient by 91 multiple physicians. 92 (b) Authorize at least one, but no more than four, 93 dispensing organizations, to ensure reasonable statewide 94 accessibility and availability as necessary for patients 95 registered in the compassionate use registry and who are 96 prescribed medical-grade marijuana under this section. The 97 department shall develop an application form and impose an 98 initial application and biennial renewal fee that is sufficient 99 to cover the costs of administering this section. An applicant 100 for approval as a dispensing organization must be able to 101 demonstrate: 102 1. The technical and technological ability to cultivate and 103 produce medical-grade marijuana. 104 2. The ability to secure the premises, resources, and 105 personnel necessary to operate as a dispensing organization. 106 3. The ability to maintain accountability of raw materials, 107 finished product, and any byproducts to prevent diversion or 108 unlawful access to or possession of these substances. 109 4. An infrastructure reasonably located to dispense 110 medical-grade marijuana to registered patients statewide or 111 regionally as determined by the department. 112 5. The financial ability to maintain operations for the 113 duration of the 2-year approval cycle. 114 6. That all owners, managers, and employees have been 115 fingerprinted and successfully passed background screening 116 pursuant to s. 435.04. 117 7. Additional criteria determined by the department to be 118 necessary to safely implement this section. 119 (c) Monitor physician registration and prescribing of 120 medical-grade marijuana for prescribing practices which could 121 facilitate unlawful diversion or misuse of medical-grade 122 marijuana, and take disciplinary action as indicated. 123 (4) DISPENSING ORGANIZATION.—An approved dispensing 124 organization shall maintain compliance with the criteria 125 demonstrated for selection and approval under subsection (3) as 126 a dispensing organization at all times. Before dispensing 127 medical-grade marijuana to a qualified patient, the dispensing 128 organization shall verify that the patient has an active 129 registration in the compassionate use registry, the prescription 130 presented matches the prescription contents as recorded in the 131 registry, and the prescription has not already been filled. Upon 132 dispensing the medical-grade marijuana, the dispensing 133 organization shall record in the registry the date, time, 134 quantity, and form of medical-grade marijuana dispensed. 135 (5) EXCEPTIONS TO OTHER SECTIONS OF LAW.— 136 (a) Notwithstanding any other section of law, but subject 137 to the requirements of this section, a qualified patient and the 138 qualified patient’s legal representative may purchase, acquire, 139 and possess for the patient’s medical use up to the amount of 140 medical-grade marijuana prescribed to the patient. 141 (b) Notwithstanding any other section of law, but subject 142 to the requirements of this section, an approved dispensing 143 organization and its owners, managers, and employees may 144 acquire, possess, cultivate, and lawfully dispose of excess 145 product in reasonable quantities to produce medical-grade 146 marijuana and possess, process, and dispense medical-grade 147 marijuana. 148 (c) An approved dispensing organization is not subject to 149 licensure and regulation under chapter 465, and the owners, 150 managers, and employees of a dispensing organization are not 151 subject to licensure and regulation for the practice of pharmacy 152 under chapter 465. 153 Section 2. Subsection (3) of section 893.02, Florida 154 Statutes, is amended to read: 155 893.02 Definitions.—The following words and phrases as used 156 in this chapter shall have the following meanings, unless the 157 context otherwise requires: 158 (3) “Cannabis” means all parts of any plant of the genus 159 Cannabis, whether growing or not; the seeds thereof; the resin 160 extracted from any part of the plant; and every compound, 161 manufacture, salt, derivative, mixture, or preparation of the 162 plant or its seeds or resin. The term does not include any plant 163 of the genus Cannabis that contains 0.5 percent or less of 164 tetrahydrocannabinol and more than 15 percent of cannabidiol; 165 the seeds thereof; the resin extracted from any part of such 166 plant; or any compound, manufacture, salt, derivative, mixture, 167 or preparation of such plant or its seeds or resin, if possessed 168 or used in conformance with s. 456.60. 169 Section 3. This act shall take effect July 1, 2014.